Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2766.1 3
0310-0617
654.98 617.44 437 77.26 0.920
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 556.4 3
0311-0620
691.40 620.80 264 62.77 0.842
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1048.8 3
0312-0622
316.84 621.70 292 62.77 0.931
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1514.4 3
0313-0628
613.04 628.45 215 54.87 0.897
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3623.7 3
0314-0632
119.71 632.15 422 75.36 0.934
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 408.9 3
0315-0630
340.94 629.63 275 65.60 0.803
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 438.1 3
0316-0635
406.97 634.37 580 95.98 0.791
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 727.1 3
0317-0634
44.10 633.95 263 62.77 0.839
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1757.4 3
0318-0637
939.48 637.54 249 58.53 0.913
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3979.8 3
0319-0643
596.50 643.24 346 69.60 0.898
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 301.1 3
0320-0642
345.82 643.74 326 71.01 0.812
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2024.8 3
0321-0643
892.99 643.52 199 54.87 0.831
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1317.8 3
0322-0645
755.67 644.84 283 62.43 0.913
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1181.7 3
0323-0647
849.47 645.85 284 66.43 0.809
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1412.0 3
0324-0645
915.19 645.36 189 50.53 0.930
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 468.6 3
0325-0648
719.79 648.20 266 63.60 0.826
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 617.9 3
0326-0650
46.59 649.98 241 58.77 0.877
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 832.0 3
0327-0654
672.21 654.89 277 62.77 0.883
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 458.7 3
0328-0659
482.69 658.41 319 68.67 0.850
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1827.3 3
0329-0656
415.05 657.27 273 64.18 0.833
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1541.1 3
0330-0661
817.85 661.10 226 55.11 0.935
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 633.4 3
0331-0662
381.27 662.38 254 60.53 0.871
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 368.7 3
0332-0664
602.31 664.16 276 61.94 0.904
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 585.7 3
0333-0665
260.71 665.53 161 46.87 0.921
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1297.2 3
0334-0669
166.07 669.08 291 63.94 0.894